Basal-like breast cancer, often triple-negative, is frequently associated with high genomic instability and homologous recombination (HR) deficiency, which typically results from BRCA1 mutations or dysfunctions (Lord and Ashworth, 2016). The gene discussed is BRCA1; the disease is breast cancer.